Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (2 ops.)
Latest filing published 29 Jul 2009 for ENDOCARE INC.
Insider track record
Disclosed buys
9
Disclosed sells
2
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas R. Testman: trading record in brief
Thomas R. Testman is a declared insider at 2 companies; the most frequent names are Endocare Inc and Amylin Pharmaceuticals Inc. In total, 19 filings cover trades dated from 25 August 2006 to 27 July 2009.
On the open market, the record shows 9 purchases worth €24k and 2 sales worth €1.1M. The net balance comes to €1.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 option exercises.
A typical purchase (the median) is worth €1,568.
The record was last updated on 29 July 2009 with an option exercise in Endocare Inc. The last purchase on record was published on 16 August 2007, which is 7,009 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas R. Testman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
9,202 sharesCommon StockSEC:0001209191-09-038079:0
53,158 sharesCommon StockSEC:0001209191-09-038079:1
62,360 sharesCommon StockSEC:0001209191-09-038079:2
5,000 sharesCommon StockSEC:0001209191-09-038079:3
7,142 sharesCommon StockSEC:0001209191-09-027599:0
2,060 sharesCommon StockSEC:0001209191-09-002739:0
4,500 shares@ US$2.10Common StockSEC:0001209191-07-048872:0
Canonical exit: 14 Nov 2007 (T+90)
500 shares@ US$2.05Common StockSEC:0001209191-07-048872:1
Canonical exit: 14 Nov 2007 (T+90)
500 shares@ US$2.03Common StockSEC:0001209191-07-048872:2
Canonical exit: 14 Nov 2007 (T+90)
1,000 shares@ US$2.00Common StockSEC:0001209191-07-048872:3
Canonical exit: 14 Nov 2007 (T+90)
12,000 shares@ US$16.23Common StockSEC:0001367982-07-000278:0
12,000 shares@ US$46.62Common StockSEC:0001367982-07-000278:1
20,000 shares@ US$16.99Common StockSEC:0001367982-07-000257:0
20,000 shares@ US$44.88Common StockSEC:0001367982-07-000257:1
1,500 shares@ US$2.10Common StockSEC:0001209191-06-048122:0
Canonical exit: 27 Nov 2006 (T+90)
1,000 shares@ US$2.00Common StockSEC:0001209191-06-047817:0
Canonical exit: 23 Nov 2006 (T+90)
1,000 shares@ US$1.98Common StockSEC:0001209191-06-047817:1
Canonical exit: 23 Nov 2006 (T+90)
1,500 shares@ US$2.05Common StockSEC:0001209191-06-047817:2
Canonical exit: 26 Nov 2006 (T+90)
3,500 shares@ US$2.10Common StockSEC:0001209191-06-047817:3
Canonical exit: 26 Nov 2006 (T+90)
19 of 19 declarations
